SCHEMBL22573532

SCHEMBL22573532

Cc1cc(NC(=O)c2cnc(-c3ccccn3)nc2N)no1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.57
▸ ALDH1A1 P00352 5/20 0.57
▸ TSHR P16473 3/20 0.57
▸ HPGD P15428 3/20 0.57
▸ MAPT P10636 2/20 0.57
▸ HSD17B10 Q99714 2/20 0.57
▸ USP2 O75604 1/20 0.57
▸ XBP1 P17861 1/20 0.57
▸ NPSR1 Q6W5P4 1/20 0.57
▸ MEN1 O00255 3/20 0.56
▸ KMT2A Q03164 3/20 0.56
▸ RXFP1 Q9HBX9 1/20 0.56
▸ RAB9A P51151 7/20 0.55
▸ NPC1 O15118 6/20 0.55
▸ SMN1; SMN2 Q16637 4/20 0.51
▸ CYP1A2 P05177 2/20 0.51
▸ CYP2C19 P33261 2/20 0.51
▸ SLC2A1 P11166 1/20 0.48
▸ LMNA P02545 1/20 0.47
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22573723 0.85 RAB9A (0.59) KDM4EALDH1A1TSHRHPGDMAPT
SCHEMBL22574062 0.84 GRM5 (0.54) KDM4EMEN1KMT2ARAB9ANPC1
SCHEMBL22573696 0.83 ATM (0.56) ALDH1A1HPGDMEN1KMT2ARAB9A
SCHEMBL22573629 0.82 GRM5 (0.63) ALDH1A1HPGDHSD17B10KMT2ARAB9A
SCHEMBL22573756 0.82 NPC1 (0.56) KDM4EALDH1A1TSHRHPGDMAPT
SCHEMBL22573853 0.82 ALDH1A1 (0.53) KDM4EALDH1A1TSHRHPGDMAPT
SCHEMBL22573737 0.82 KDM4E (0.59) KDM4EALDH1A1TSHRHPGDMAPT
SCHEMBL22573343 0.80 TSHR (0.58) KDM4EALDH1A1TSHRHPGDMAPT
SCHEMBL22573273 0.80 HPGDS (0.47) KDM4EALDH1A1MAPTMEN1KMT2A
SCHEMBL22573837 0.80 ATR (0.51) KDM4EALDH1A1HPGDMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP claimed
EP-3728236-A1 PYRIMIDINE DERIVATIVES AND THEIR USE USE FOR THE TREATMENT OF CANCER Adorx therapeutics Limited (GB) 2020-10-28 — — EP disclosed
Send feedback